Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Leticia Norma Carpentieri
Data de Publicação: 2019
Outros Autores: Tavares, Anna Carollina Moraes, Ferreira, Beatriz Tavares, Reis, Adriana Karla Cardoso Amorim, Katiki, Luciana Morita
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/164794
Resumo: Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates.
id USP-31_6972ad732df8999217166e955212a621
oai_identifier_str oai:revistas.usp.br:article/164794
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazolesCyclodextrins/pharmacokineticsBenzimidazoles/administration & dosageInclusion complexesCyclodextrin aggregatesDrug liberation/drug effectsAntiparasitic agents/analysisAlbendazole/analysisFenbendazole/analysisAlbendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16479410.1590/s2175-97902019000117776Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17776Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e177762175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164794/157978Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues, Leticia Norma CarpentieriTavares, Anna Carollina MoraesFerreira, Beatriz TavaresReis, Adriana Karla Cardoso AmorimKatiki, Luciana Morita2021-01-11T18:41:22Zoai:revistas.usp.br:article/164794Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T18:41:22Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
title Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
spellingShingle Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
Rodrigues, Leticia Norma Carpentieri
Cyclodextrins/pharmacokinetics
Benzimidazoles/administration & dosage
Inclusion complexes
Cyclodextrin aggregates
Drug liberation/drug effects
Antiparasitic agents/analysis
Albendazole/analysis
Fenbendazole/analysis
title_short Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
title_full Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
title_fullStr Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
title_full_unstemmed Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
title_sort Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
author Rodrigues, Leticia Norma Carpentieri
author_facet Rodrigues, Leticia Norma Carpentieri
Tavares, Anna Carollina Moraes
Ferreira, Beatriz Tavares
Reis, Adriana Karla Cardoso Amorim
Katiki, Luciana Morita
author_role author
author2 Tavares, Anna Carollina Moraes
Ferreira, Beatriz Tavares
Reis, Adriana Karla Cardoso Amorim
Katiki, Luciana Morita
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues, Leticia Norma Carpentieri
Tavares, Anna Carollina Moraes
Ferreira, Beatriz Tavares
Reis, Adriana Karla Cardoso Amorim
Katiki, Luciana Morita
dc.subject.por.fl_str_mv Cyclodextrins/pharmacokinetics
Benzimidazoles/administration & dosage
Inclusion complexes
Cyclodextrin aggregates
Drug liberation/drug effects
Antiparasitic agents/analysis
Albendazole/analysis
Fenbendazole/analysis
topic Cyclodextrins/pharmacokinetics
Benzimidazoles/administration & dosage
Inclusion complexes
Cyclodextrin aggregates
Drug liberation/drug effects
Antiparasitic agents/analysis
Albendazole/analysis
Fenbendazole/analysis
description Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-05
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164794
10.1590/s2175-97902019000117776
url https://www.revistas.usp.br/bjps/article/view/164794
identifier_str_mv 10.1590/s2175-97902019000117776
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164794/157978
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17776
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222914498265088